Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
News-Medical.Net on MSN
AI system spots Parkinson’s signs in voice, walking and drawings
By Dr. Liji Thomas, MD By merging voice instability, gait asymmetry, and tremor-driven handwriting changes into a single explainable AI framework, researchers show how digital biomarkers can move ...
NORTH CHICAGO, Ill., Dec. 2, 2025 /PRNewswire/ -- AbbVie today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research ...
Neuroimaging provides a means for identifying and measuring the structure and function of the brain. Different non-invasive imaging measurements reveal different characteristics of the nervous system, ...
A clinician, advocate, and payer provide their expert knowledge on the multiple modalities of PrEP therapy and how some can be more beneficial than others.
Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results